Literature DB >> 25566406

A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient.

Heun Choi1, Hye Won Lee1, Hea Won Ann1, Jae Kyung Kim1, Hua Pyong Kang1, Sun Wook Kim1, Nam Su Ku2, Sang Hoon Han2, June Myung Kim2, Jun Yong Choi2.   

Abstract

Diffuse large B cell lymphoma (DLBCL) is one of the most common acquired immune deficiency syndrome (AIDS)-defining malignancies among human immunodeficiency virus-infected patients, and rectal cancer has recently emerged as a prevalent non-AIDS-defining malignancy. We report a case of rectal squamous cell carcinoma that was metachronous with DLBCL in an HIV-infected patient who was receiving highly active antiretroviral therapy. The patient was diagnosed with DLBCL and showed complete remission after chemotherapy. Follow-up imaging showed increased uptake at the rectum, previously treated as lymphoma. Repeated biopsy was performed and squamous cell carcinoma of the rectum was reported. After concurrent chemoradiation therapy, curative resection was performed.

Entities:  

Keywords:  AIDS-related lymphoma; HIV; Oncogenic viruses; Squamous cell carcinoma

Year:  2014        PMID: 25566406      PMCID: PMC4285004          DOI: 10.3947/ic.2014.46.4.257

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


  14 in total

1.  Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy.

Authors:  G V Matthews; M Bower; S Mandalia; T Powles; M R Nelson; B G Gazzard
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

2.  Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.

Authors:  Nancy Crum-Cianflone; Katherine Huppler Hullsiek; Vincent Marconi; Amy Weintrob; Anuradha Ganesan; R Vincent Barthel; Susan Fraser; Brian K Agan; Scott Wegner
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

3.  Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

Authors:  Frank J Palella; Rose K Baker; Anne C Moorman; Joan S Chmiel; Kathleen C Wood; John T Brooks; Scott D Holmberg
Journal:  J Acquir Immune Defic Syndr       Date:  2006-09       Impact factor: 3.731

4.  Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Authors:  Judith E Sackoff; David B Hanna; Melissa R Pfeiffer; Lucia V Torian
Journal:  Ann Intern Med       Date:  2006-09-19       Impact factor: 25.391

5.  Relationship between prevalent oral and cervical human papillomavirus infections in human immunodeficiency virus-positive and -negative women.

Authors:  Carole Fakhry; Gypsyamber D'souza; Elizabeth Sugar; Kathleen Weber; Eleni Goshu; Howard Minkoff; Rodney Wright; Eric Seaberg; Maura Gillison
Journal:  J Clin Microbiol       Date:  2006-10-04       Impact factor: 5.948

Review 6.  Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy.

Authors:  Lindsay R Barclay; Susan E Buskin; Erin M Kahle; David M Aboulafia
Journal:  Clin Lymphoma Myeloma       Date:  2007-01

7.  Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.

Authors:  C Besson; A Goubar; J Gabarre; W Rozenbaum; G Pialoux; F P Châtelet; C Katlama; F Charlotte; B Dupont; N Brousse; M Huerre; J Mikol; P Camparo; K Mokhtari; M Tulliez; D Salmon-Céron; F Boué; D Costagliola; M Raphaël
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Anal and perianal squamous carcinomas and high-grade intraepithelial lesions exclusively associated with "low-risk" HPV genotypes 6 and 11.

Authors:  Alyssa M Cornall; Jennifer M Roberts; Suzanne M Garland; Richard J Hillman; Andrew E Grulich; Sepehr N Tabrizi
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

9.  Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003.

Authors:  Pragna Patel; Debra L Hanson; Patrick S Sullivan; Richard M Novak; Anne C Moorman; Tony C Tong; Scott D Holmberg; John T Brooks
Journal:  Ann Intern Med       Date:  2008-05-20       Impact factor: 25.391

10.  Spectrum of AIDS-associated malignant disorders.

Authors:  J J Goedert; T R Coté; P Virgo; S M Scoppa; D W Kingma; M H Gail; E S Jaffe; R J Biggar
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

View more
  5 in total

1.  Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?

Authors:  Anna E Coghill; Meredith S Shiels; Randi K Rycroft; Glenn Copeland; Jack L Finch; Anne M Hakenewerth; Karen S Pawlish; Eric A Engels
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

2.  Synchronous and Metachronous Malignant Epithelial and Lymphoid Tumors: a Clinicopathologic Study of 10 Patientszzm321990from a Major Tertiary Care Center in Pakistan

Authors:  Nasir Ud Din; Zubair Ahmad; Khurram Minhas; Zeeshan Uddin; Arsalan Ahmed
Journal:  Asian Pac J Cancer Prev       Date:  2017-08-27

3.  Gemcitabine-based chemotherapy in colon squamous cell carcinoma: A case report and literature review.

Authors:  Shufen Zhao; Jing Guo; Libin Sun; Jing Lv; Wensheng Qiu
Journal:  Mol Clin Oncol       Date:  2017-03-01

4.  Primary squamous cell carcinoma of the rectum: An update and implications for treatment.

Authors:  Glen R Guerra; Cherng H Kong; Satish K Warrier; Andrew C Lynch; Alexander G Heriot; Samuel Y Ngan
Journal:  World J Gastrointest Surg       Date:  2016-03-27

5.  Construction and validation of a prognostic nomogram for anal squamous cell carcinoma.

Authors:  Ningning Yang; Lu Xu; Qingqing Wang; Fengxia Chen; Yunfeng Zhou
Journal:  Cancer Med       Date:  2021-12-01       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.